MMP-9 catalytic site inhibiting mAb (MabTrix)

N/A

Report date: 2026/04/01 10:12:10

Base Information

Drug NameMMP-9 catalytic site inhibiting mAb (MabTrix)
Drug Alias NameMMP-9 catalytic site inhibiting mAb (Weizmann)inhibitory mAbs (Weizmann)metallobodies (Weizmann)matrix metalloproteinase-9 catalytic site inhibiting mAb (Weizmann)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYeda Research and Development Co LtdWeizmann Institute Of Science
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A